Am J Perinatol 2007; 24(1): 027-031
DOI: 10.1055/s-2006-958157
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Hypothermia for the Treatment of Neonatal Ischemic Encephalopathy: Is the Genie out of the Bottle?

Tara R. Lang1 , Tyler K.M Hartman1 , Susan R. Hintz2 , Christopher E. Colby1
  • 1Department of Pediatrics, Mayo Clinic, Rochester, Minnesota
  • 2Department of Pediatrics, Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, California
Further Information

Publication History

Publication Date:
27 December 2006 (online)

Preview

ABSTRACT

Evidence suggests that hypothermia for hypoxic ischemic encephalopathy in the term neonate may decrease the risk of death or neurodevelopmental impairment. The objective of this study was to determine how hypothermia has been incorporated into practice. An anonymous survey was sent to medical directors of United States neonatal intensive care units (NICUs) in October 2005. We received completed surveys from 441 (54.5%) of 809 of NICUs. Only 6.4% of respondents used hypothermia. The most common method was total body cooling (64.3%) compared with head cooling (25%) or both (10.7%). At centers that did not offer hypothermia, 29% transferred infants to an institution that did. Centers that offered hypothermia were more likely at academic institutions (76.9%) compared with private practices (11.5%; p < 0.001). Hypothermia was more likely offered at institutions that offered extracorporeal membrane oxygenation (ECMO; 57%) than centers where ECMO was not offered (43%; p < 0.001). There has not been widespread use of hypothermia. There are a variety of protocols used. As results of further outcome studies become available, educational efforts and national practice guidelines will be essential.

REFERENCES

Christopher E ColbyM.D. 

Assistant Professor of Pediatrics, Department of Pediatrics, Mayo Clinic

200 First Street SW, Rochester, MN 55905